APA (7th ed.) Citation

K, T., M, S., K, S., K, H., S, N., I, C., . . . H, N. (2026). Systemic administration of liposomal trehalose dimycolate induces NK1.1⁺ cell mediated antitumor immunity in bladder cancer. BMC cancer, 26(1), . https://doi.org/10.1186/s12885-026-15951-1

Chicago Style (17th ed.) Citation

K, Tanuma, et al. "Systemic Administration of Liposomal Trehalose Dimycolate Induces NK1.1⁺ Cell Mediated Antitumor Immunity in Bladder Cancer." BMC Cancer 26, no. 1 (2026). https://doi.org/10.1186/s12885-026-15951-1.

MLA (9th ed.) Citation

K, Tanuma, et al. "Systemic Administration of Liposomal Trehalose Dimycolate Induces NK1.1⁺ Cell Mediated Antitumor Immunity in Bladder Cancer." BMC Cancer, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12885-026-15951-1.